What is the half-life of Nifedipine (Calcium Channel Blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Half-life of Nifedipine

Nifedipine has a short half-life of approximately 2 hours in its immediate-release formulation, while extended-release formulations have a longer half-life of approximately 7 hours. 1

Pharmacokinetic Properties of Nifedipine

Immediate-Release Formulation

  • Half-life: Approximately 2 hours 1
  • Absorption: Almost completely absorbed from the gastrointestinal tract 2
  • Bioavailability: 56% to 77% (due to presystemic metabolism) 2
  • Peak plasma concentration: Reached within 30-60 minutes after oral administration 2
  • Elimination: Biphasic with initial alpha-phase half-life of about 13 minutes and beta-phase half-life of about 1.26 hours 2

Extended-Release Formulation

  • Half-life: Approximately 7 hours 1
  • Peak plasma concentration: Occurs at about 2.5-5 hours post-dose with a second small peak at 6-12 hours 1
  • Metabolism: Extensively metabolized via cytochrome P450 3A4 system 1
  • Excretion: 60-80% of the dose excreted in urine as water-soluble inactive metabolites; less than 0.1% excreted unchanged in urine; remainder excreted in feces 1

Clinical Implications of Half-Life

Dosing Frequency

  • Immediate-release nifedipine: Requires multiple daily dosing due to short half-life 3
  • Extended-release formulations: Allow for once-daily dosing 1

Safety Considerations

  • Immediate-release nifedipine is not recommended for hypertensive crisis or unstable angina/NSTEMI except with concomitant beta blockade due to risk of adverse cardiovascular events 3
  • The short half-life of immediate-release nifedipine can lead to rapid fluctuations in blood pressure, potentially causing reflex tachycardia 4
  • Extended-release formulations provide more stable plasma concentrations, reducing the risk of adverse effects 5

Stability Considerations

  • Nifedipine is unstable when stored at room temperature (25°C) for more than 1 day 3
  • For laboratory testing purposes, samples containing nifedipine should be stored at -20°C for stability 3

Comparison with Other Calcium Channel Blockers

Drug Half-Life Duration of Action
Nifedipine (immediate-release) ~2 hours Short
Nifedipine (extended-release) ~7 hours Long
Amlodipine 34-50 hours Long
Diltiazem Variable (short for immediate-release, long for extended-release) Short to Long
Verapamil Variable (short for immediate-release, long for extended-release) Short to Long

The relatively short half-life of nifedipine compared to other calcium channel blockers like amlodipine (34-50 hours) explains why immediate-release nifedipine requires multiple daily dosing while amlodipine can be administered once daily 3.

Understanding the half-life of nifedipine is critical for appropriate dosing, patient adherence, and minimizing adverse effects related to rapid fluctuations in drug concentration.

References

Research

Pharmacokinetics and metabolism of nifedipine.

Hypertension (Dallas, Tex. : 1979), 1983

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety of Immediate-Release Nifedipine.

Journal of cardiovascular pharmacology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.